Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

1. Katagiri, Y.
2. Onuma, Y.
3. Asano, T.
4. Iniguez, A.
5. Jensen, L.O.
6. Cequier, À.
7. Hofma, S.H.
8. Christiansen, E.H.
9. Suttorp, M.
10. Brugaletta, S.
11. Räber, L.
12. Sabaté, M.
13. Windecker, S.
14. Serruys, P.W.